Benjamin Frey

48PUBLICATIONS
99CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Environmental biogeochemistryTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Oct 07, 2026
TCASIA: an integrative atlas linking alternative splicing landscapes for cancer immunotherapy.

|Jan 16, 2026
Newly Identified Transcriptomic Biomarkers and Gene Signature of Pathological Complete Response to Induction Chemoimmunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.

Jian-Guo Zhou, Markus Eckstein, Haitao Wang

|Dec 30, 2025
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as a Biomarker for Radiation Dosimetry and Health Risk Assessment: A Review.

Kave Moloudi, Traimate Sangsuwan, Satoru Monzen

|Oct 16, 2025
Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Cancers 2022, 14, 326.

Bin Lan, Siyuan Zeng, Shuman Zhang

|Jul 29, 2025
Chemoradiation-Altered Micromilieu of Glioblastoma Cells Particularly Impacts M1-like Macrophage Activation.

Mona Shojaei, Benjamin Frey, Florian Putz

|May 14, 2025
Early Detection and Longitudinal Follow-Up of Non-Invasive Biomarkers for Laryngeal Squamous Cell Carcinoma: First Results of the BEAL-Study.

Ann-Christin Winkelmann, Olaf Wendler, Johannes Schuster

Pageof 8

Frequent Collaborators

33 joint publications

Udo S Gaipl

13 joint publications

Markus Hecht

8 joint publications

Lisa Deloch

8 joint publications

Jian-Guo Zhou